Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

Treating Myelofibrosis in 2021: What Are the Efficacy Data for Ruxolitinib? Is Allo-HCT a Good Curative Option in Advanced Disease?

170 views
June 11, 2021
Comments 0
Login to view comments. Click here to Login